| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.673 | 0.013 | 0.673 | Antiobesity | |||
| 0.616 | 0.006 | 0.616 | GABA C receptor rho-3 antagonist | 0.615 0.006 CID_992 | ||
| 0.609 | 0.018 | 0.678 | Aldehyde oxidase inhibitor | 0.678 0.01 CID_992 | CID_992 | |
| 0.564 | 0.018 | 0.564 | 5 Hydroxytryptamine release stimulant | 0.541 0.021 CID_992 | ||
| 0.563 | 0.017 | 0.563 | 5 Hydroxytryptamine release inhibitor | 0.513 0.029 CID_992 | ||
| 0.521 | 0.025 | 0.521 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.446 0.064 CID_992 | ||
| 0.483 | 0.011 | 0.633 | Peroxidase inhibitor | 0.633 0.004 CID_992 | CID_992 | |
| 0.471 | 0.009 | 0.471 | Dual specificity phosphatase 3 inhibitor | 0.433 0.011 CID_992 | ||
| 0.464 | 0.006 | 0.486 | Alpha-N-acetylglucosaminidase inhibitor | 0.486 0.005 CID_992 | CID_992 | |
| 0.46 | 0.006 | 0.464 | 5 Hydroxytryptamine uptake stimulant | 0.464 0.006 CID_992 | CID_992 | |
| 0.44 | 0.005 | 0.44 | Glutamate receptor antagonist | 0.254 0.015 CID_992 | ||
| 0.423 | 0.012 | 0.569 | Dual specificity phosphatase inhibitor | 0.569 0.005 CID_992 | CID_992 | |
| 0.47 | 0.073 | 0.561 | Caspase 9 stimulant | 0.561 0.042 CID_992 | CID_992 | |
| 0.444 | 0.049 | 0.638 | Immunosuppressant | 0.638 0.009 CID_992 | CID_992 | |
| 0.41 | 0.021 | 0.41 | Calcium channel activator | 0.364 0.041 CID_992 | ||
| 0.39 | 0.006 | 0.39 | UDP-glucose 4-epimerase inhibitor | 0.342 0.008 CID_992 | ||
| 0.383 | 0.005 | 0.407 | GABA C receptor agonist | 0.407 0.005 CID_992 | CID_992 | |
| 0.382 | 0.004 | 0.382 | Succinate dehydrogenase inhibitor | 0.375 0.005 CID_992 | ||
| 0.375 | 0.005 | 0.375 | Cystathionine beta-synthase inhibitor | 0.34 0.007 CID_992 | ||
| 0.419 | 0.051 | 0.419 | Calpain 2 inhibitor | 0.243 0.154 CID_992 | ||
| 0.37 | 0.004 | 0.37 | Ferrochelatase inhibitor | 0.297 0.008 CID_992 | ||
| 0.398 | 0.048 | 0.398 | Streptokinase A inhibitor | 0.386 0.051 CID_992 | ||
| 0.363 | 0.013 | 0.407 | Tyrosine 3 hydroxylase inhibitor | 0.407 0.007 CID_992 | CID_992 | |
| 0.35 | 0.004 | 0.35 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.286 0.007 CID_992 | ||
| 0.395 | 0.05 | 0.426 | Cholesterol antagonist | 0.426 0.045 CID_992 | CID_992 | |
| 0.341 | 0.003 | 0.341 | Glutamate release inhibitor | 0.202 0.005 CID_992 | ||
| 0.326 | 0.005 | 0.326 | CC chemokine receptor antagonist | |||
| 0.323 | 0.006 | 0.323 | Chemokine receptor antagonist | |||
| 0.313 | 0.009 | 0.326 | Nitric-oxide synthase stimulant | 0.326 0.007 CID_992 | CID_992 | |
| 0.34 | 0.039 | 0.383 | Superoxide dismutase inhibitor | 0.383 0.03 CID_992 | CID_992 | |
| 0.345 | 0.049 | 0.345 | Aryl hydrocarbon receptor agonist | 0.188 0.109 CID_992 | ||
| 0.376 | 0.088 | 0.418 | Histamine release inhibitor | 0.418 0.066 CID_992 | CID_992 | |
| 0.288 | 0.004 | 0.288 | EphA2 antagonist | |||
| 0.311 | 0.029 | 0.336 | RNA-directed DNA polymerase inhibitor | 0.336 0.026 CID_992 | CID_992 | |
| 0.287 | 0.011 | 0.287 | Cell adhesion inhibitor | |||
| 0.28 | 0.016 | 0.28 | 3C-like protease (Human coronavirus) inhibitor | 0.201 0.051 CID_992 | ||
| 0.294 | 0.034 | 0.294 | 5 Hydroxytryptamine 1E antagonist | 0.248 0.077 CID_992 | ||
| 0.263 | 0.004 | 0.263 | Liver X receptor agonist | 0.223 0.004 CID_992 | ||
| 0.267 | 0.009 | 0.277 | Mannose-6-phosphate isomerase inhibitor | 0.277 0.008 CID_992 | CID_992 | |
| 0.267 | 0.01 | 0.267 | 5 Hydroxytryptamine 3E antagonist | 0.22 0.036 CID_992 | ||
| 0.29 | 0.035 | 0.295 | Anesthetic general | 0.295 0.034 CID_992 | CID_992 | |
| 0.288 | 0.042 | 0.288 | Gastrin inhibitor | 0.232 0.102 CID_992 | ||
| 0.249 | 0.003 | 0.323 | Liver X receptor alpha antagonist | 0.323 0.003 CID_992 | CID_992 | |
| 0.255 | 0.011 | 0.255 | GABA C receptor rho-2 antagonist | 0.237 0.015 CID_992 | ||
| 0.258 | 0.014 | 0.258 | Ephrin antagonist | |||
| 0.253 | 0.008 | 0.253 | 5 Hydroxytryptamine uptake inhibitor | |||
| 0.256 | 0.012 | 0.256 | ATPase inhibitor | 0.207 0.032 CID_992 | ||
| 0.247 | 0.005 | 0.247 | Electrolyte absorption antagonist | 0.244 0.005 CID_992 | ||
| 0.244 | 0.003 | 0.244 | Nicotinic acid receptor 1 agonist | 0.076 0.011 CID_992 | ||
| 0.246 | 0.008 | 0.369 | NADH dehydrogenase inhibitor | 0.369 0.005 CID_992 | CID_992 | |
| 0.328 | 0.091 | 0.466 | Prostaglandin dehydrogenase inhibitor | 0.466 0.049 CID_992 | CID_992 | |
| 0.286 | 0.049 | 0.287 | DNA synthesis inhibitor | 0.287 0.048 CID_992 | CID_992 | |
| 0.239 | 0.005 | 0.239 | Adrenaline uptake inhibitor | 0.101 0.018 CID_992 | ||
| 0.241 | 0.01 | 0.241 | NMDA receptor antagonist | 0.156 0.023 CID_992 | ||
| 0.257 | 0.026 | 0.257 | Amylase inhibitor | 0.245 0.029 CID_992 | ||
| 0.237 | 0.007 | 0.243 | GABA C receptor antagonist | 0.243 0.007 CID_992 | CID_992 | |
| 0.265 | 0.036 | 0.283 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.283 0.029 CID_992 | CID_992 | |
| 0.234 | 0.005 | 0.234 | Protein kinase B gamma inhibitor | |||
| 0.276 | 0.049 | 0.276 | Psychostimulant | 0.15 0.116 CID_992 | ||
| 0.265 | 0.042 | 0.265 | Neuropeptide Y2 antagonist | 0.216 0.094 CID_992 | ||
| 0.23 | 0.007 | 0.23 | ABCA1 expression enhancer | 0.147 0.018 CID_992 | ||
| 0.227 | 0.005 | 0.227 | Nav1.8 sodium channel blocker | |||
| 0.228 | 0.008 | 0.228 | 5 Hydroxytryptamine 3A agonist | 0.199 0.015 CID_992 | ||
| 0.22 | 0.004 | 0.22 | CC chemokine receptor 2B antagonist | |||
| 0.221 | 0.005 | 0.221 | Purinergic P2 antagonist | |||
| 0.223 | 0.008 | 0.294 | Creatine kinase inhibitor | 0.294 0.004 CID_992 | CID_992 | |
| 0.328 | 0.112 | 0.469 | 15-Lipoxygenase inhibitor | 0.469 0.048 CID_992 | CID_992 | |
| 0.219 | 0.004 | 0.282 | Liver X receptor antagonist | 0.282 0.003 CID_992 | CID_992 | |
| 0.221 | 0.009 | 0.221 | Triose-phosphate isomerase inhibitor | 0.221 0.009 CID_992 | ||
| 0.266 | 0.06 | 0.266 | Potassium channel (Voltage-sensitive) blocker | |||
| 0.237 | 0.031 | 0.336 | Heat shock protein 90 alpha antagonist | 0.336 0.01 CID_992 | CID_992 | |
| 0.228 | 0.025 | 0.228 | Alkaline phosphatase inhibitor | 0.182 0.041 CID_992 | ||
| 0.207 | 0.004 | 0.207 | Lanosterol 14 alpha demethylase inhibitor | 0.145 0.013 CID_992 | ||
| 0.277 | 0.074 | 0.314 | Insulysin inhibitor | 0.314 0.05 CID_992 | CID_992 | |
| 0.206 | 0.004 | 0.206 | Aryl hydrocarbon receptor antagonist | 0.095 0.016 CID_992 | ||
| 0.213 | 0.012 | 0.213 | Potassium channel (Ca-activated) activator | 0.158 0.025 CID_992 | ||
| 0.257 | 0.058 | 0.257 | Calpain inhibitor | 0.182 0.132 CID_992 | ||
| 0.217 | 0.019 | 0.229 | Arachidonic acid antagonist | 0.229 0.012 CID_992 | CID_992 | |
| 0.207 | 0.01 | 0.207 | HIV-1 integrase (Overall Integration) inhibitor | 0.207 0.01 CID_992 | ||
| 0.22 | 0.025 | 0.22 | Hexokinase inhibitor | 0.187 0.043 CID_992 | ||
| 0.198 | 0.004 | 0.198 | Purinergic P2X antagonist | |||
| 0.195 | 0.004 | 0.195 | Ca2+-transporting ATPase inhibitor | 0.193 0.004 CID_992 | ||
| 0.194 | 0.003 | 0.194 | Purinergic P2X7 antagonist | |||
| 0.196 | 0.007 | 0.196 | Potassium channel large-conductance Ca-activated activator | 0.119 0.017 CID_992 | ||
| 0.247 | 0.058 | 0.247 | Anticonvulsant | |||
| 0.287 | 0.099 | 0.308 | Vasodilator, coronary | 0.308 0.081 CID_992 | CID_992 | |
| 0.233 | 0.049 | 0.265 | Neurotrophic factor enhancer | 0.265 0.031 CID_992 | CID_992 | |
| 0.202 | 0.018 | 0.202 | Carbonic anhydrase XV inhibitor | 0.179 0.022 CID_992 | ||
| 0.192 | 0.009 | 0.192 | GABA C receptor rho-1 antagonist | 0.173 0.014 CID_992 | ||
| 0.187 | 0.005 | 0.187 | NMDA receptor subunit 3B antagonist | 0.135 0.007 CID_992 | ||
| 0.284 | 0.104 | 0.322 | Transcription factor NF kappa B inhibitor | 0.322 0.085 CID_992 | CID_992 | |
| 0.254 | 0.076 | 0.255 | Interleukin agonist | 0.255 0.075 CID_992 | CID_992 | |
| 0.206 | 0.028 | 0.206 | Cell wall synthesis inhibitor | 0.171 0.047 CID_992 | ||
| 0.206 | 0.029 | 0.206 | Cyclooxygenase 2 inhibitor | |||
| 0.261 | 0.085 | 0.261 | Ca(v)3.3 blocker | |||
| 0.202 | 0.026 | 0.202 | Cholesterol synthesis inhibitor | 0.183 0.031 CID_992 | ||
| 0.305 | 0.132 | 0.398 | Antibacterial | 0.398 0.078 CID_992 | CID_992 | |
| 0.211 | 0.038 | 0.211 | Cyclooxygenase inhibitor | |||
| 0.27 | 0.098 | 0.417 | 12-Lipoxygenase inhibitor | 0.417 0.035 CID_992 | CID_992 | |
| 0.188 | 0.017 | 0.202 | Adenylate kinase inhibitor | 0.202 0.015 CID_992 | CID_992 | |
| 0.185 | 0.014 | 0.249 | Porphobilinogen synthase inhibitor | 0.249 0.008 CID_992 | CID_992 | |
| 0.174 | 0.005 | 0.174 | NMDA receptor agonist | 0.11 0.016 CID_992 | ||
| 0.184 | 0.016 | 0.184 | Pregnane X receptor agonist | 0.158 0.039 CID_992 | ||
| 0.206 | 0.039 | 0.217 | Interferon gamma antagonist | 0.217 0.035 CID_992 | CID_992 | |
| 0.18 | 0.015 | 0.18 | Sphingosine 1-phosphate receptor 4 antagonist | 0.17 0.019 CID_992 | ||
| 0.201 | 0.037 | 0.294 | Heat shock protein 90 antagonist | 0.294 0.011 CID_992 | CID_992 | |
| 0.186 | 0.025 | 0.186 | Nav1.6 sodium channel blocker | 0.113 0.107 CID_992 | ||
| 0.17 | 0.013 | 0.17 | NMDA 2 receptor antagonist | 0.1 0.032 CID_992 | ||
| 0.166 | 0.009 | 0.255 | Alcohol oxidase inhibitor | 0.255 0.005 CID_992 | CID_992 | |
| 0.161 | 0.005 | 0.161 | NMDA receptor subunit 3A antagonist | 0.105 0.008 CID_992 | ||
| 0.176 | 0.02 | 0.176 | Catalase inhibitor | 0.147 0.027 CID_992 | ||
| 0.167 | 0.014 | 0.204 | DOPA decarboxylase inhibitor | 0.204 0.006 CID_992 | CID_992 | |
| 0.268 | 0.115 | 0.268 | Vasodilator, peripheral | 0.225 0.149 CID_992 | ||
| 0.156 | 0.005 | 0.156 | D-Ala-D-Ala ligase inhibitor | 0.149 0.005 CID_992 | ||
| 0.169 | 0.018 | 0.169 | Heat shock protein 70 antagonist | 0.16 0.028 CID_992 | ||
| 0.197 | 0.046 | 0.211 | Phospholipase C inhibitor | 0.211 0.037 CID_992 | CID_992 | |
| 0.153 | 0.004 | 0.153 | NMDA receptor glycine site agonist | 0.111 0.012 CID_992 | ||
| 0.161 | 0.014 | 0.161 | CYP2A6 inhibitor | 0.077 0.051 CID_992 | ||
| 0.15 | 0.003 | 0.15 | Exportin-1 inhibitor | 0.091 0.014 CID_992 | ||
| 0.174 | 0.029 | 0.174 | Sphingosine 1-phosphate receptor 5 antagonist | 0.169 0.035 CID_992 | ||
| 0.152 | 0.007 | 0.152 | NMDA 2C receptor antagonist | 0.1 0.016 CID_992 | ||
| 0.169 | 0.024 | 0.169 | Interleukin 8 antagonist | 0.142 0.039 CID_992 | ||
| 0.175 | 0.03 | 0.199 | Adenylate cyclase stimulant | 0.199 0.014 CID_992 | CID_992 | |
| 0.15 | 0.006 | 0.15 | Dopamine transporter inhibitor | 0.055 0.028 CID_992 | ||
| 0.178 | 0.038 | 0.195 | CF transmembrane conductance regulator agonist | 0.195 0.024 CID_992 | CID_992 | |
| 0.15 | 0.011 | 0.174 | Carbamoyl phosphate synthetase inhibitor | 0.174 0.009 CID_992 | CID_992 | |
| 0.152 | 0.013 | 0.152 | Cyclin B3 inhibitor | |||
| 0.174 | 0.036 | 0.188 | Aldehyde dehydrogenase inhibitor | 0.188 0.031 CID_992 | CID_992 | |
| 0.17 | 0.033 | 0.177 | Cyclooxygenase 3 inhibitor | 0.177 0.029 CID_992 | CID_992 | |
| 0.243 | 0.107 | 0.356 | Hypoxia-inducible factor 1 alpha inhibitor | 0.356 0.043 CID_992 | CID_992 | |
| 0.156 | 0.02 | 0.156 | Urease inhibitor | 0.142 0.027 CID_992 | ||
| 0.138 | 0.004 | 0.138 | Glucagon-like peptide 1 receptor antagonist | |||
| 0.143 | 0.009 | 0.143 | Glycine receptor antagonist | 0.131 0.013 CID_992 | ||
| 0.151 | 0.018 | 0.185 | Phosphofructokinase-1 inhibitor | 0.185 0.013 CID_992 | CID_992 | |
| 0.177 | 0.043 | 0.177 | Nav1.2 sodium channel blocker | |||
| 0.152 | 0.019 | 0.328 | Histidine decarboxylase inhibitor | 0.328 0.005 CID_992 | CID_992 | |
| 0.221 | 0.089 | 0.327 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.327 0.057 CID_992 | CID_992 | |
| 0.286 | 0.153 | 0.286 | Analgesic | |||
| 0.139 | 0.006 | 0.139 | Neurokinin 2 antagonist | |||
| 0.142 | 0.01 | 0.142 | Biliverdin reductase inhibitor | 0.121 0.014 CID_992 | ||
| 0.135 | 0.004 | 0.135 | Glutamate (mGluR6) antagonist | 0.104 0.009 CID_992 | ||
| 0.166 | 0.036 | 0.166 | Cathepsin H inhibitor | 0.137 0.057 CID_992 | ||
| 0.146 | 0.016 | 0.146 | Cell adhesion molecule inhibitor | |||
| 0.293 | 0.163 | 0.326 | Alpha-glucosidase inhibitor | 0.326 0.147 CID_992 | CID_992 | |
| 0.14 | 0.01 | 0.14 | Sphingosine 1-phosphate receptor 4 agonist | 0.092 0.029 CID_992 | ||
| 0.233 | 0.103 | 0.37 | Immunostimulant | 0.37 0.059 CID_992 | CID_992 | |
| 0.23 | 0.101 | 0.23 | Transcription factor STAT3 inhibitor | 0.191 0.147 CID_992 | ||
| 0.145 | 0.016 | 0.145 | Histamine N-methyltransferase inhibitor | 0.117 0.032 CID_992 | ||
| 0.159 | 0.031 | 0.161 | Sphingosine 1-phosphate receptor 2 antagonist | 0.161 0.028 CID_992 | CID_992 | |
| 0.13 | 0.002 | 0.13 | Phenylethanolamine N methyltransferase inhibitor | 0.061 0.007 CID_992 | ||
| 0.179 | 0.051 | 0.188 | Neurotensin receptor agonist | 0.188 0.042 CID_992 | CID_992 | |
| 0.198 | 0.072 | 0.198 | Non-steroidal antiinflammatory agent | 0.147 0.118 CID_992 | ||
| 0.15 | 0.025 | 0.15 | Beta glucuronidase inhibitor | 0.131 0.037 CID_992 | ||
| 0.141 | 0.015 | 0.141 | Glutamate (mGluR7) agonist | 0.102 0.056 CID_992 | ||
| 0.21 | 0.085 | 0.21 | HERG channel blocker | |||
| 0.208 | 0.085 | 0.218 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | 0.218 0.078 CID_992 | CID_992 | |
| 0.164 | 0.04 | 0.164 | Nav1.3 sodium channel blocker | |||
| 0.145 | 0.021 | 0.153 | Anabolic | 0.153 0.017 CID_992 | CID_992 | |
| 0.128 | 0.005 | 0.128 | Vanilloid 4 agonist | 0.107 0.012 CID_992 | ||
| 0.134 | 0.011 | 0.134 | GABA aminotransferase inhibitor | 0.125 0.014 CID_992 | ||
| 0.227 | 0.105 | 0.283 | Transcription factor STAT inhibitor | 0.283 0.066 CID_992 | CID_992 | |
| 0.156 | 0.035 | 0.162 | Aminopeptidase B inhibitor | 0.162 0.033 CID_992 | CID_992 | |
| 0.167 | 0.046 | 0.167 | MAP kinase 3 inhibitor | 0.137 0.091 CID_992 | ||
| 0.201 | 0.081 | 0.201 | MAP kinase kinase 2 inhibitor | 0.151 0.12 CID_992 | ||
| 0.167 | 0.049 | 0.167 | Cyclooxygenase 1 inhibitor | 0.109 0.091 CID_992 | ||
| 0.164 | 0.046 | 0.164 | Sodium channel (voltage-gated) blocker | |||
| 0.136 | 0.018 | 0.159 | Glutamate dehydrogenase inhibitor | 0.159 0.014 CID_992 | CID_992 | |
| 0.141 | 0.025 | 0.141 | Androgen antagonist | 0.12 0.033 CID_992 | ||
| 0.139 | 0.022 | 0.139 | Aminoacyl-tRNA synthetase inhibitor | |||
| 0.127 | 0.012 | 0.127 | Acyl-CoA dehydrogenase inhibitor | 0.12 0.013 CID_992 | ||
| 0.141 | 0.026 | 0.141 | Folate antagonist | |||
| 0.144 | 0.029 | 0.148 | Transcription factor STAT6 inhibitor | 0.148 0.025 CID_992 | CID_992 | |
| 0.12 | 0.006 | 0.12 | Phospholipase D inhibitor | 0.091 0.021 CID_992 | ||
| 0.168 | 0.055 | 0.168 | Thiol protease inhibitor | |||
| 0.162 | 0.049 | 0.162 | Neuropeptide Y1 antagonist | 0.127 0.107 CID_992 | ||
| 0.162 | 0.05 | 0.162 | Sodium channel blocker | |||
| 0.135 | 0.023 | 0.136 | MAP kinase kinase 1 inhibitor | 0.136 0.023 CID_992 | CID_992 | |
| 0.117 | 0.005 | 0.117 | Potassium channel intermediate-conductance Ca-activated blocker | 0.056 0.05 CID_992 | ||
| 0.203 | 0.092 | 0.203 | Cyclic AMP phosphodiesterase inhibitor | 0.17 0.122 CID_992 | ||
| 0.127 | 0.016 | 0.177 | Phenylalanine 4-hydroxylase inhibitor | 0.177 0.009 CID_992 | CID_992 | |
| 0.112 | 0.003 | 0.129 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.129 0.002 CID_992 | CID_992 | |
| 0.158 | 0.05 | 0.158 | Toll-Like receptor antagonist | 0.141 0.063 CID_992 | ||
| 0.176 | 0.068 | 0.176 | Antipruritic | |||
| 0.116 | 0.009 | 0.126 | GABA B receptor agonist | 0.126 0.006 CID_992 | CID_992 | |
| 0.169 | 0.062 | 0.247 | Diuretic | 0.247 0.031 CID_992 | CID_992 | |
| 0.171 | 0.065 | 0.171 | Catenin beta inhibitor | |||
| 0.111 | 0.006 | 0.111 | Nicotinic alpha3beta2 receptor antagonist | 0.059 0.028 CID_992 | ||
| 0.107 | 0.003 | 0.107 | Integrin alpha1beta1 antagonist | 0.056 0.005 CID_992 | ||
| 0.108 | 0.004 | 0.108 | Potassium channel small-conductance Ca-activated activator | |||
| 0.121 | 0.017 | 0.121 | Nicotinic alpha4beta2 receptor antagonist | |||
| 0.123 | 0.02 | 0.16 | Glutamate decarboxylase inhibitor | 0.16 0.011 CID_992 | CID_992 | |
| 0.153 | 0.051 | 0.16 | M18 aspartyl aminopeptidase inhibitor | 0.16 0.048 CID_992 | CID_992 | |
| 0.116 | 0.014 | 0.143 | Glycine receptor agonist | 0.143 0.008 CID_992 | CID_992 | |
| 0.123 | 0.02 | 0.123 | Cannabinoid receptor antagonist | |||
| 0.129 | 0.028 | 0.129 | Potassium channel activator | |||
| 0.104 | 0.003 | 0.108 | Pregnane X receptor antagonist | 0.108 0.003 CID_992 | CID_992 | |
| 0.105 | 0.004 | 0.105 | CC chemokine 4 receptor antagonist | 0.046 0.034 CID_992 | ||
| 0.107 | 0.007 | 0.107 | Aconitate hydratase inhibitor | 0.092 0.01 CID_992 | ||
| 0.104 | 0.004 | 0.104 | Potassium channel (Inward rectifier) activator | 0.061 0.018 CID_992 | ||
| 0.132 | 0.032 | 0.132 | Acetylcholine release stimulant | 0.106 0.074 CID_992 | ||
| 0.135 | 0.038 | 0.135 | AMP-activated protein kinase stimulant | 0.118 0.05 CID_992 | ||
| 0.135 | 0.038 | 0.135 | Nav1.5 sodium channel blocker | |||
| 0.103 | 0.006 | 0.103 | Corticotropin releasing factor 2 receptor antagonist | 0.069 0.029 CID_992 | ||
| 0.12 | 0.023 | 0.12 | Bromodomain-containing protein 2 inhibitor | 0.094 0.048 CID_992 | ||
| 0.11 | 0.013 | 0.11 | Cannabinoid CB1 receptor antagonist | |||
| 0.101 | 0.004 | 0.101 | Potassium channel (ATP-sensitive) activator | 0.058 0.017 CID_992 | ||
| 0.115 | 0.019 | 0.117 | Granulocyte macrophage colony stimulating factor agonist | 0.117 0.018 CID_992 | CID_992 | |
| 0.108 | 0.013 | 0.109 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.109 0.013 CID_992 | CID_992 | |
| 0.147 | 0.053 | 0.154 | MAP kinase kinase inhibitor | 0.154 0.049 CID_992 | CID_992 | |
| 0.129 | 0.035 | 0.129 | Sphingomyelinase inhibitor | 0.119 0.042 CID_992 | ||
| 0.16 | 0.068 | 0.16 | Cytidine deaminase inhibitor | 0.157 0.07 CID_992 | ||
| 0.18 | 0.088 | 0.18 | Focal adhesion kinase 2 inhibitor | |||
| 0.101 | 0.01 | 0.101 | Glutamate (mGluR7) antagonist | 0.085 0.022 CID_992 | ||
| 0.108 | 0.017 | 0.108 | Dopamine uptake inhibitor | 0.06 0.038 CID_992 | ||
| 0.267 | 0.175 | 0.267 | Transcription factor inhibitor | |||
| 0.095 | 0.004 | 0.095 | NMDA receptor glycine site antagonist | 0.045 0.007 CID_992 | ||
| 0.095 | 0.004 | 0.095 | Glutamate (mGluR3) antagonist | 0.05 0.012 CID_992 | ||
| 0.129 | 0.039 | 0.162 | Carbonic anhydrase III inhibitor | 0.162 0.024 CID_992 | CID_992 | |
| 0.105 | 0.015 | 0.14 | Purinergic P2X1 antagonist | 0.14 0.008 CID_992 | CID_992 | |
| 0.093 | 0.003 | 0.093 | Heme oxygenase inhibitor | 0.057 0.008 CID_992 | ||
| 0.102 | 0.013 | 0.102 | Autotaxin inhibitor | |||
| 0.101 | 0.013 | 0.101 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.087 0.026 CID_992 | ||
| 0.121 | 0.034 | 0.121 | Calcium antagonist | |||
| 0.171 | 0.086 | 0.225 | DNA methyltransferase I inhibitor | 0.225 0.057 CID_992 | CID_992 | |
| 0.105 | 0.019 | 0.124 | Estrogen-related receptor beta agonist | 0.124 0.009 CID_992 | CID_992 | |
| 0.094 | 0.009 | 0.094 | MDM2 inhibitor | 0.082 0.018 CID_992 | ||
| 0.182 | 0.097 | 0.182 | Histone acetyltransferase inhibitor | |||
| 0.202 | 0.118 | 0.202 | Spasmolytic | 0.199 0.12 CID_992 | ||
| 0.112 | 0.028 | 0.112 | Bile acid receptor antagonist | 0.111 0.03 CID_992 | ||
| 0.121 | 0.037 | 0.141 | Prolactin inhibitor | 0.141 0.026 CID_992 | CID_992 | |
| 0.099 | 0.015 | 0.099 | 5 Hydroxytryptamine 2A agonist | 0.055 0.052 CID_992 | ||
| 0.108 | 0.024 | 0.109 | Aminopeptidase I inhibitor | 0.109 0.023 CID_992 | CID_992 | |
| 0.108 | 0.025 | 0.108 | mTOR complex 2 inhibitor | 0.095 0.039 CID_992 | ||
| 0.111 | 0.029 | 0.111 | Telomerase inhibitor | |||
| 0.087 | 0.005 | 0.122 | Dopamine D5 agonist | 0.122 0.003 CID_992 | CID_992 | |
| 0.088 | 0.007 | 0.088 | Glutamate (mGluR4) antagonist | 0.044 0.03 CID_992 | ||
| 0.15 | 0.068 | 0.152 | Protein kinase stimulant | 0.152 0.067 CID_992 | CID_992 | |
| 0.119 | 0.038 | 0.119 | DNA directed RNA polymerase inhibitor | |||
| 0.087 | 0.007 | 0.097 | Glucose-6-phosphate isomerase inhibitor | 0.097 0.005 CID_992 | CID_992 | |
| 0.099 | 0.019 | 0.099 | Potassium channel Kv1.5 blocker | |||
| 0.128 | 0.049 | 0.131 | TRPA1 agonist | 0.131 0.047 CID_992 | CID_992 | |
| 0.108 | 0.03 | 0.108 | ATPase (Vacuolar H+) inhibitor | |||
| 0.135 | 0.058 | 0.138 | Vanilloid 1 agonist | 0.138 0.053 CID_992 | CID_992 | |
| 0.108 | 0.031 | 0.129 | Glutathione S-transferase inhibitor | 0.129 0.018 CID_992 | CID_992 | |
| 0.097 | 0.02 | 0.112 | Argininosuccinate synthase inhibitor | 0.112 0.017 CID_992 | CID_992 | |
| 0.28 | 0.203 | 0.339 | MAP kinase 1 inhibitor | 0.339 0.144 CID_992 | CID_992 | |
| 0.093 | 0.017 | 0.093 | Cannabinoid CB2 receptor antagonist | |||
| 0.11 | 0.034 | 0.118 | Carbonic anhydrase VI inhibitor | 0.118 0.03 CID_992 | CID_992 | |
| 0.102 | 0.026 | 0.102 | Caspase 7 inhibitor | 0.081 0.058 CID_992 | ||
| 0.142 | 0.067 | 0.142 | Neurotrophic factor | |||
| 0.091 | 0.016 | 0.091 | Potassium channel (Tandem pore domain) blocker | |||
| 0.152 | 0.078 | 0.216 | Melanin inhibitor | 0.216 0.035 CID_992 | CID_992 | |
| 0.099 | 0.025 | 0.099 | T cell inhibitor | |||
| 0.085 | 0.011 | 0.085 | Calcium channel P-type blocker | 0.074 0.021 CID_992 | ||
| 0.113 | 0.04 | 0.127 | Alcohol dehydrogenase inhibitor | 0.127 0.03 CID_992 | CID_992 | |
| 0.081 | 0.008 | 0.083 | Adenylate cyclase 1 inhibitor | 0.083 0.007 CID_992 | CID_992 | |
| 0.13 | 0.057 | 0.13 | Beta amyloid protein antagonist | |||
| 0.078 | 0.005 | 0.078 | Potassium channel Kv1.1 blocker | 0.038 0.026 CID_992 | ||
| 0.126 | 0.054 | 0.161 | Microtubule formation inhibitor | 0.161 0.032 CID_992 | CID_992 | |
| 0.124 | 0.052 | 0.128 | Photosensitizer | 0.128 0.049 CID_992 | CID_992 | |
| 0.084 | 0.013 | 0.084 | Sphingosine kinase 2 inhibitor | 0.074 0.019 CID_992 | ||
| 0.119 | 0.049 | 0.188 | Protein kinase (CK2) inhibitor | 0.188 0.021 CID_992 | CID_992 | |
| 0.087 | 0.017 | 0.087 | NMDA 2A receptor antagonist | 0.057 0.032 CID_992 | ||
| 0.149 | 0.08 | 0.149 | Cyclin-dependent kinase 8 inhibitor | |||
| 0.075 | 0.005 | 0.075 | 5 Hydroxytryptamine 2B agonist | |||
| 0.09 | 0.02 | 0.09 | 5 Hydroxytryptamine 3 agonist | 0.068 0.038 CID_992 | ||
| 0.078 | 0.009 | 0.078 | Bradykinin antagonist | |||
| 0.217 | 0.148 | 0.257 | Thyroid hormone antagonist | 0.257 0.119 CID_992 | CID_992 | |
| 0.083 | 0.014 | 0.083 | 5 Hydroxytryptamine 2 agonist | |||
| 0.11 | 0.041 | 0.11 | Potassium channel (Voltage-sensitive) activator | |||
| 0.173 | 0.104 | 0.173 | Insulin sensitizer | 0.169 0.108 CID_992 | ||
| 0.088 | 0.02 | 0.088 | Androgen agonist | 0.08 0.024 CID_992 | ||
| 0.079 | 0.011 | 0.085 | Dihydroorotate oxidase inhibitor | 0.085 0.008 CID_992 | CID_992 | |
| 0.121 | 0.053 | 0.121 | Falcipain 3 inhibitor | 0.114 0.058 CID_992 | ||
| 0.093 | 0.025 | 0.093 | Acetylcholine M5 receptor agonist | |||
| 0.075 | 0.008 | 0.075 | Kainate receptor 2 antagonist | 0.031 0.029 CID_992 | ||
| 0.255 | 0.188 | 0.255 | DNA directed DNA polymerase inhibitor | 0.236 0.2 CID_992 | ||
| 0.134 | 0.067 | 0.143 | NADPH oxidase inhibitor | 0.143 0.059 CID_992 | CID_992 | |
| 0.211 | 0.145 | 0.243 | Thyroid hormone beta antagonist | 0.243 0.123 CID_992 | CID_992 | |
| 0.168 | 0.102 | 0.219 | DNA methylase inhibitor | 0.219 0.067 CID_992 | CID_992 | |
| 0.146 | 0.08 | 0.146 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | |||
| 0.07 | 0.005 | 0.07 | Kynurenine 3 monooxygenase inhibitor | 0.03 0.015 CID_992 | ||
| 0.102 | 0.037 | 0.104 | Carbonic anhydrase XIII inhibitor | 0.104 0.036 CID_992 | CID_992 | |
| 0.081 | 0.016 | 0.081 | Botulinum neurotoxin type A inhibitor | 0.075 0.021 CID_992 | ||
| 0.069 | 0.005 | 0.069 | Nerve growth factor antagonist | 0.058 0.011 CID_992 | ||
| 0.084 | 0.02 | 0.106 | Beta 3 adrenoreceptor antagonist | 0.106 0.013 CID_992 | CID_992 | |
| 0.072 | 0.008 | 0.072 | Nicotinic acid receptor agonist | 0.054 0.013 CID_992 | ||
| 0.071 | 0.008 | 0.077 | Dopamine beta hydroxylase inhibitor | 0.077 0.005 CID_992 | CID_992 | |
| 0.08 | 0.017 | 0.08 | Toll-Like receptor 8 antagonist | |||
| 0.072 | 0.01 | 0.072 | Immunoglobulin Fc receptor antagonist | 0.059 0.027 CID_992 | ||
| 0.068 | 0.007 | 0.068 | Dihydrofolate reductase inhibitor | 0.041 0.036 CID_992 | ||
| 0.106 | 0.044 | 0.106 | Protein kinase C zeta inhibitor | 0.089 0.067 CID_992 | ||
| 0.07 | 0.008 | 0.071 | Fumarate hydratase inhibitor | 0.071 0.008 CID_992 | CID_992 | |
| 0.069 | 0.008 | 0.069 | Alpha 1d adrenoreceptor agonist | 0.054 0.014 CID_992 | ||
| 0.075 | 0.014 | 0.075 | Glutamate (mGluR group III) agonist | 0.041 0.033 CID_992 | ||
| 0.075 | 0.015 | 0.075 | Epithelial sodium channel blocker | 0.056 0.036 CID_992 | ||
| 0.077 | 0.018 | 0.077 | Phosphorylase inhibitor | 0.04 0.037 CID_992 | ||
| 0.066 | 0.007 | 0.066 | Bradykinin B1 receptor antagonist | |||
| 0.089 | 0.03 | 0.089 | Carbonic anhydrase VA inhibitor | 0.071 0.045 CID_992 | ||
| 0.069 | 0.01 | 0.069 | Glutamate (mGluR group III) antagonist | 0.041 0.037 CID_992 | ||
| 0.092 | 0.033 | 0.096 | CC chemokine 5 receptor agonist | 0.096 0.027 CID_992 | CID_992 | |
| 0.124 | 0.065 | 0.124 | DNA repair enzyme inhibitor | 0.118 0.077 CID_992 | ||
| 0.075 | 0.018 | 0.147 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.147 0.005 CID_992 | CID_992 | |
| 0.081 | 0.024 | 0.081 | 5 Hydroxytryptamine 3 antagonist | |||
| 0.096 | 0.04 | 0.096 | Myeloperoxidase inhibitor | 0.089 0.051 CID_992 | ||
| 0.061 | 0.005 | 0.061 | ATP citrate lysase inhibitor | 0.058 0.005 CID_992 | ||
| 0.065 | 0.009 | 0.065 | Benzodiazepine antagonist | |||
| 0.088 | 0.032 | 0.088 | Carbonic anhydrase V inhibitor | 0.068 0.045 CID_992 | ||
| 0.079 | 0.023 | 0.079 | Carbonic anhydrase VB inhibitor | 0.069 0.028 CID_992 | ||
| 0.105 | 0.049 | 0.105 | Falcipain 2 inhibitor | |||
| 0.151 | 0.096 | 0.151 | LIM domain kinase 1 inhibitor | |||
| 0.093 | 0.038 | 0.101 | Na+ K+ transporting ATPase inhibitor | 0.101 0.031 CID_992 | CID_992 | |
| 0.066 | 0.011 | 0.066 | Purinergic P2X4 antagonist | 0.054 0.02 CID_992 | ||
| 0.059 | 0.005 | 0.088 | CF transmembrane conductance regulator antagonist | 0.088 0.003 CID_992 | CID_992 | |
| 0.064 | 0.01 | 0.064 | Glutamate (mGluR group II) antagonist | 0.048 0.017 CID_992 | ||
| 0.062 | 0.008 | 0.062 | Alpha 1L adrenoreceptor agonist | |||
| 0.058 | 0.005 | 0.058 | Vanilloid 3 antagonist | 0.045 0.013 CID_992 | ||
| 0.076 | 0.023 | 0.087 | Heat shock protein 90 beta antagonist | 0.087 0.016 CID_992 | CID_992 | |
| 0.092 | 0.039 | 0.105 | Macrophage migration inhibitory factor inhibitor | 0.105 0.032 CID_992 | CID_992 | |
| 0.104 | 0.052 | 0.104 | Falcipain inhibitor | |||
| 0.114 | 0.063 | 0.114 | Alpha 2b adrenoreceptor antagonist | |||
| 0.086 | 0.034 | 0.086 | Benzodiazepine agonist | |||
| 0.085 | 0.034 | 0.097 | MAP kinase kinase 7 inhibitor | 0.097 0.016 CID_992 | CID_992 | |
| 0.065 | 0.014 | 0.065 | Kainate receptor antagonist | |||
| 0.124 | 0.074 | 0.167 | Toll-Like receptor 2 antagonist | 0.167 0.041 CID_992 | CID_992 | |
| 0.158 | 0.109 | 0.257 | Pyruvate kinase inhibitor | 0.257 0.059 CID_992 | CID_992 | |
| 0.057 | 0.008 | 0.061 | Glutamate (mGluR8) agonist | 0.061 0.007 CID_992 | CID_992 | |
| 0.057 | 0.008 | 0.061 | Kainate receptor agonist | 0.061 0.007 CID_992 | CID_992 | |
| 0.054 | 0.005 | 0.054 | LFA antagonist | |||
| 0.078 | 0.03 | 0.078 | Cannabinoid CB1 receptor agonist | |||
| 0.073 | 0.025 | 0.073 | Enoyl-[acyl-carrier-protein] reductase inhibitor | 0.06 0.042 CID_992 | ||
| 0.063 | 0.016 | 0.063 | Fructose-1,6-bisphosphatase inhibitor | 0.043 0.034 CID_992 | ||
| 0.076 | 0.029 | 0.076 | Carbonic anhydrase IX inhibitor | 0.076 0.029 CID_992 | ||
| 0.063 | 0.016 | 0.063 | Glutamate (mGluR5) agonist | |||
| 0.064 | 0.017 | 0.064 | Aldosterone antagonist | |||
| 0.064 | 0.018 | 0.064 | Squalene epoxidase inhibitor | 0.059 0.021 CID_992 | ||
| 0.089 | 0.044 | 0.113 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.113 0.032 CID_992 | CID_992 | |
| 0.07 | 0.025 | 0.07 | CC chemokine 2 receptor antagonist | |||
| 0.057 | 0.012 | 0.064 | Phosphoglycerate kinase inhibitor | 0.064 0.01 CID_992 | CID_992 | |
| 0.056 | 0.011 | 0.056 | Histamine H1 receptor agonist | |||
| 0.067 | 0.022 | 0.067 | Glycine transporter inhibitor | |||
| 0.072 | 0.028 | 0.072 | EphB4 antagonist | 0.052 0.047 CID_992 | ||
| 0.079 | 0.035 | 0.084 | Carbonic anhydrase inhibitor | 0.084 0.033 CID_992 | CID_992 | |
| 0.062 | 0.018 | 0.072 | Carbonic anhydrase VII inhibitor | 0.072 0.014 CID_992 | CID_992 | |
| 0.109 | 0.066 | 0.13 | Mucolytic | 0.13 0.045 CID_992 | CID_992 | |
| 0.071 | 0.028 | 0.071 | Carbonic anhydrase I inhibitor | 0.052 0.042 CID_992 | ||
| 0.114 | 0.071 | 0.114 | Calcium channel N-type blocker | |||
| 0.053 | 0.01 | 0.053 | Integrin alpha2 antagonist | 0.04 0.021 CID_992 | ||
| 0.069 | 0.026 | 0.071 | Ornithine carbamoyltransferase inhibitor | 0.071 0.025 CID_992 | CID_992 | |
| 0.083 | 0.041 | 0.083 | Cathepsin G inhibitor | 0.067 0.057 CID_992 | ||
| 0.063 | 0.021 | 0.063 | Glutamate (mGluR group I) agonist | |||
| 0.057 | 0.015 | 0.057 | Thymidine kinase inhibitor | 0.047 0.021 CID_992 | ||
| 0.064 | 0.022 | 0.071 | Alpha-mannosidase inhibitor | 0.071 0.016 CID_992 | CID_992 | |
| 0.056 | 0.015 | 0.057 | Guanylate cyclase inhibitor | 0.057 0.015 CID_992 | CID_992 | |
| 0.049 | 0.008 | 0.049 | Protein kinase (CK2) beta inhibitor | 0.042 0.011 CID_992 | ||
| 0.079 | 0.038 | 0.079 | Amidase inhibitor | |||
| 0.055 | 0.015 | 0.069 | Liver X receptor alpha agonist | 0.069 0.009 CID_992 | CID_992 | |
| 0.046 | 0.006 | 0.054 | CXC chemokine 2 receptor antagonist | 0.054 0.005 CID_992 | CID_992 | |
| 0.053 | 0.013 | 0.053 | AMPA 4 receptor antagonist | 0.042 0.024 CID_992 | ||
| 0.048 | 0.008 | 0.048 | Ceramide glucosyltransferase inhibitor | 0.043 0.013 CID_992 | ||
| 0.061 | 0.021 | 0.061 | Heparanase inhibitor | 0.054 0.035 CID_992 | ||
| 0.06 | 0.021 | 0.081 | Adenosine deaminase inhibitor | 0.081 0.009 CID_992 | CID_992 | |
| 0.076 | 0.037 | 0.076 | Nav1.7 sodium channel blocker | |||
| 0.056 | 0.017 | 0.056 | Geranyltranstransferase inhibitor | 0.054 0.019 CID_992 | ||
| 0.132 | 0.093 | 0.132 | Acetylcholine M1 receptor antagonist | |||
| 0.106 | 0.067 | 0.106 | Protein kinase C gamma inhibitor | |||
| 0.058 | 0.019 | 0.058 | Cholesterol esterase inhibitor | |||
| 0.054 | 0.016 | 0.054 | GABA B receptor antagonist | 0.044 0.028 CID_992 | ||
| 0.086 | 0.048 | 0.086 | Glutamate receptor agonist | |||
| 0.061 | 0.023 | 0.061 | Prolyl endopeptidase inhibitor | 0.051 0.035 CID_992 | ||
| 0.111 | 0.074 | 0.111 | Caspase 3 inhibitor | 0.103 0.087 CID_992 | ||
| 0.056 | 0.019 | 0.056 | Dihydroorotase inhibitor | 0.045 0.031 CID_992 | ||
| 0.063 | 0.026 | 0.063 | Dopamine D4 agonist | |||
| 0.055 | 0.018 | 0.055 | Histamine H2 receptor agonist | |||
| 0.068 | 0.031 | 0.074 | Carbonic anhydrase II inhibitor | 0.074 0.028 CID_992 | CID_992 | |
| 0.069 | 0.032 | 0.069 | Alpha 2 adrenoreceptor agonist | |||
| 0.075 | 0.038 | 0.075 | Glucagon-like peptide 1 agonist | |||
| 0.067 | 0.03 | 0.067 | Carbonic anhydrase XII inhibitor | 0.044 0.043 CID_992 | ||
| 0.069 | 0.032 | 0.069 | Transcription factor RelA inhibitor | 0.067 0.035 CID_992 | ||
| 0.068 | 0.032 | 0.073 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.073 0.028 CID_992 | CID_992 | |
| 0.053 | 0.017 | 0.053 | Dopamine D3 agonist | |||
| 0.111 | 0.075 | 0.132 | Adenylate cyclase inhibitor | 0.132 0.058 CID_992 | CID_992 | |
| 0.044 | 0.008 | 0.044 | Nicotinic alpha3beta4 receptor agonist | 0.031 0.019 CID_992 | ||
| 0.058 | 0.023 | 0.058 | CD45 antagonist | 0.051 0.034 CID_992 | ||
| 0.077 | 0.041 | 0.077 | Prostaglandin-E synthase inhibitor | |||
| 0.051 | 0.016 | 0.051 | Substance P antagonist | |||
| 0.119 | 0.083 | 0.119 | Antibacterial (Helicobacter pylori) | |||
| 0.045 | 0.01 | 0.06 | Liver X receptor beta antagonist | 0.06 0.005 CID_992 | CID_992 | |
| 0.164 | 0.129 | 0.164 | Antiamyloidogenic | 0.16 0.134 CID_992 | ||
| 0.085 | 0.05 | 0.085 | Acetylcholine nicotinic antagonist | |||
| 0.044 | 0.01 | 0.044 | Glutamate (mGluR2) antagonist | 0.033 0.016 CID_992 | ||
| 0.067 | 0.032 | 0.067 | Cyclin D1 inhibitor | 0.056 0.05 CID_992 | ||
| 0.04 | 0.006 | 0.04 | Integrin alpha2beta1 antagonist | 0.029 0.013 CID_992 | ||
| 0.04 | 0.006 | 0.04 | MAP3K8 inhibitor | 0.028 0.023 CID_992 | ||
| 0.04 | 0.007 | 0.044 | Purinergic P2Y15 antagonist | 0.044 0.005 CID_992 | CID_992 | |
| 0.059 | 0.025 | 0.059 | AMPA receptor antagonist | |||
| 0.062 | 0.029 | 0.062 | Glucosylceramidase inhibitor | 0.056 0.036 CID_992 | ||
| 0.205 | 0.171 | 0.212 | Antithrombotic | 0.212 0.163 CID_992 | CID_992 | |
| 0.038 | 0.005 | 0.04 | Hedgehog signaling activator | 0.04 0.004 CID_992 | CID_992 | |
| 0.04 | 0.007 | 0.04 | Thymidine phosphorylase inhibitor | 0.033 0.009 CID_992 | ||
| 0.045 | 0.012 | 0.045 | Free fatty acid receptor 1 antagonist | |||
| 0.04 | 0.007 | 0.04 | Corticotropin releasing factor 1 receptor antagonist | |||
| 0.047 | 0.014 | 0.047 | Delayed rectifier potassium channel blocker | |||
| 0.187 | 0.154 | 0.307 | Lipoxygenase inhibitor | 0.307 0.068 CID_992 | CID_992 | |
| 0.079 | 0.047 | 0.09 | Sphingosine 1-phosphate receptor antagonist | 0.09 0.03 CID_992 | CID_992 | |
| 0.049 | 0.017 | 0.049 | Dihydropteroate synthase inhibitor | 0.044 0.022 CID_992 | ||
| 0.078 | 0.046 | 0.078 | Adenosine A3 receptor antagonist | |||
| 0.042 | 0.01 | 0.042 | Methionyl aminopeptidase 1 inhibitor | |||
| 0.075 | 0.043 | 0.075 | Secretase beta inhibitor | |||
| 0.053 | 0.021 | 0.053 | Stearoyl-CoA desaturase inhibitor | |||
| 0.083 | 0.052 | 0.083 | Ca(v)3.1 blocker | |||
| 0.057 | 0.026 | 0.057 | Bombesin 2 receptor antagonist | 0.046 0.041 CID_992 | ||
| 0.046 | 0.015 | 0.05 | RNA-directed RNA polymerase inhibitor | 0.05 0.013 CID_992 | CID_992 | |
| 0.233 | 0.203 | 0.233 | DNA polymerase beta inhibitor | 0.23 0.204 CID_992 | ||
| 0.039 | 0.009 | 0.039 | Prostaglandin EP2 agonist | 0.038 0.009 CID_992 | ||
| 0.076 | 0.046 | 0.076 | Epoxide hydrolase inhibitor | |||
| 0.048 | 0.017 | 0.048 | GABA uptake inhibitor | 0.048 0.017 CID_992 | ||
| 0.06 | 0.03 | 0.06 | Sphingosine 1-phosphate receptor 1 antagonist | 0.056 0.037 CID_992 | ||
| 0.042 | 0.012 | 0.042 | Tryptophan 5 hydroxylase inhibitor | 0.037 0.022 CID_992 | ||
| 0.063 | 0.033 | 0.063 | Sphingosine kinase inhibitor | 0.061 0.037 CID_992 | ||
| 0.047 | 0.017 | 0.047 | Arginase inhibitor | 0.042 0.02 CID_992 | ||
| 0.038 | 0.008 | 0.038 | 5 Hydroxytryptamine 6 agonist | |||
| 0.157 | 0.128 | 0.157 | Potassium channel blocker | |||
| 0.043 | 0.014 | 0.043 | Glutamate (mGluR4) agonist | 0.032 0.027 CID_992 | ||
| 0.063 | 0.034 | 0.063 | 5 Hydroxytryptamine 6 antagonist | |||
| 0.054 | 0.025 | 0.054 | 5 Hydroxytryptamine 2C agonist | |||
| 0.052 | 0.024 | 0.052 | Nicotinic receptor alpha3 subunit antagonist | |||
| 0.07 | 0.042 | 0.07 | 5 Hydroxytryptamine 3A antagonist | |||
| 0.041 | 0.013 | 0.041 | Benzodiazepine receptor peripheral-type antagonist | |||
| 0.033 | 0.005 | 0.033 | Complement factor 1s inhibitor | 0.025 0.019 CID_992 | ||
| 0.056 | 0.028 | 0.056 | 5 Hydroxytryptamine 4 antagonist | |||
| 0.051 | 0.024 | 0.058 | Mannosidase inhibitor | 0.058 0.018 CID_992 | CID_992 | |
| 0.032 | 0.005 | 0.032 | Cyclin T1 inhibitor | 0.022 0.009 CID_992 | ||
| 0.053 | 0.026 | 0.053 | Histamine H4 receptor antagonist | |||
| 0.042 | 0.014 | 0.052 | Liver X receptor beta agonist | 0.052 0.01 CID_992 | CID_992 | |
| 0.039 | 0.012 | 0.04 | Uridine phosphorylase inhibitor | 0.04 0.012 CID_992 | CID_992 | |
| 0.078 | 0.051 | 0.107 | Estrogen receptor alpha antagonist | 0.107 0.023 CID_992 | CID_992 | |
| 0.051 | 0.024 | 0.051 | Carbonic anhydrase IV inhibitor | 0.046 0.027 CID_992 | ||
| 0.036 | 0.009 | 0.043 | Sodium/glucose cotransporter 2 inhibitor | 0.043 0.008 CID_992 | CID_992 | |
| 0.032 | 0.006 | 0.032 | Imidazoline I1 receptor antagonist | |||
| 0.059 | 0.033 | 0.059 | 5 Hydroxytryptamine 7 agonist | |||
| 0.055 | 0.029 | 0.055 | Lysophosphatidic acid 3 receptor antagonist | 0.051 0.034 CID_992 | ||
| 0.044 | 0.018 | 0.044 | Glycine transporter 1 inhibitor | |||
| 0.048 | 0.022 | 0.048 | CDK5/p25 inhibitor | 0.048 0.023 CID_992 | ||
| 0.043 | 0.018 | 0.043 | VCAM-1 antagonist | |||
| 0.043 | 0.018 | 0.043 | VCAM antagonist | |||
| 0.067 | 0.042 | 0.076 | Dopamine D1 antagonist | 0.076 0.035 CID_992 | CID_992 | |
| 0.17 | 0.145 | 0.204 | DNA damaging | 0.204 0.112 CID_992 | CID_992 | |
| 0.049 | 0.024 | 0.057 | Oxytocin agonist | 0.057 0.019 CID_992 | CID_992 | |
| 0.036 | 0.011 | 0.036 | Nicotinic alpha4beta2 receptor agonist | |||
| 0.109 | 0.085 | 0.109 | Epidermal growth factor receptor kinase inhibitor | |||
| 0.035 | 0.01 | 0.035 | CC chemokine 1 receptor antagonist | |||
| 0.037 | 0.013 | 0.037 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | 0.027 0.02 CID_992 | ||
| 0.039 | 0.014 | 0.039 | Glucagon receptor antagonist | 0.03 0.02 CID_992 | ||
| 0.039 | 0.015 | 0.039 | AMPA 1 receptor antagonist | |||
| 0.073 | 0.048 | 0.073 | Calcium channel L-type blocker | |||
| 0.049 | 0.025 | 0.049 | CC chemokine 3 receptor antagonist | |||
| 0.029 | 0.005 | 0.029 | Alpha 2a adrenoreceptor agonist | 0.02 0.009 CID_992 | ||
| 0.1 | 0.076 | 0.152 | Protein kinase (CK2) alpha inhibitor | 0.152 0.04 CID_992 | CID_992 | |
| 0.063 | 0.039 | 0.063 | TRPA1 antagonist | |||
| 0.027 | 0.004 | 0.027 | Thromboxane A2 agonist | 0.023 0.005 CID_992 | ||
| 0.028 | 0.005 | 0.028 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.025 0.008 CID_992 | ||
| 0.031 | 0.008 | 0.031 | Glutamate (mGluR1a) agonist | 0.025 0.012 CID_992 | ||
| 0.082 | 0.059 | 0.082 | Inducible nitric-oxide synthase inhibitor | |||
| 0.032 | 0.009 | 0.032 | Complement factor 1r inhibitor | |||
| 0.025 | 0.003 | 0.025 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | 0.018 0.005 CID_992 | ||
| 0.037 | 0.015 | 0.037 | Lysophosphatidic acid 2 receptor antagonist | 0.03 0.021 CID_992 | ||
| 0.031 | 0.01 | 0.031 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.029 0.013 CID_992 | ||
| 0.032 | 0.01 | 0.032 | Nicotinic acid receptor 2 antagonist | 0.029 0.015 CID_992 | ||
| 0.029 | 0.007 | 0.029 | ICAM 1 antagonist | |||
| 0.06 | 0.038 | 0.062 | Ryanodine receptor antagonist | 0.062 0.032 CID_992 | CID_992 | |
| 0.03 | 0.009 | 0.034 | Vanilloid 2 agonist | 0.034 0.006 CID_992 | CID_992 | |
| 0.043 | 0.022 | 0.043 | Membrane dipeptidase inhibitor | 0.038 0.029 CID_992 | ||
| 0.076 | 0.055 | 0.096 | Keratolytic | 0.096 0.033 CID_992 | CID_992 | |
| 0.061 | 0.04 | 0.061 | Phosphodiesterase 1A inhibitor | |||
| 0.059 | 0.038 | 0.059 | Calcium channel T-type blocker | |||
| 0.058 | 0.038 | 0.059 | Fatty acid synthase inhibitor | 0.059 0.037 CID_992 | CID_992 | |
| 0.126 | 0.106 | 0.18 | Protein-tyrosine phosphatase inhibitor | 0.18 0.056 CID_992 | CID_992 | |
| 0.053 | 0.033 | 0.053 | Prostaglandin E2 antagonist | |||
| 0.065 | 0.045 | 0.065 | Cannabinoid receptor agonist | |||
| 0.137 | 0.117 | 0.137 | Tumour necrosis factor antagonist | |||
| 0.035 | 0.016 | 0.043 | Glutamate (mGluR3) agonist | 0.043 0.008 CID_992 | CID_992 | |
| 0.126 | 0.107 | 0.126 | Sigma receptor agonist | |||
| 0.064 | 0.045 | 0.064 | Protease 3C (Human rhinovirus) inhibitor | |||
| 0.046 | 0.027 | 0.046 | Dipeptidyl peptidase IV inhibitor | |||
| 0.049 | 0.03 | 0.051 | Thymidylate synthase inhibitor | 0.051 0.026 CID_992 | CID_992 | |
| 0.055 | 0.036 | 0.055 | Thromboxane synthase inhibitor | |||
| 0.047 | 0.028 | 0.047 | Potassium channel small-conductance Ca-activated blocker | |||
| 0.024 | 0.006 | 0.024 | Alpha 2b adrenoreceptor agonist | |||
| 0.061 | 0.043 | 0.061 | Transcription factor AP-1 inhibitor | |||
| 0.036 | 0.017 | 0.041 | HCV NS5B polymerase inhibitor | 0.041 0.014 CID_992 | CID_992 | |
| 0.03 | 0.011 | 0.033 | Sodium/glucose cotransporter inhibitor | 0.033 0.009 CID_992 | CID_992 | |
| 0.028 | 0.01 | 0.028 | Fructose-1,6-bisphosphatase 1 inhibitor | 0.022 0.02 CID_992 | ||
| 0.033 | 0.016 | 0.033 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.031 0.017 CID_992 | ||
| 0.037 | 0.019 | 0.037 | Carnitine palmitoyltransferase 1 inhibitor | |||
| 0.072 | 0.055 | 0.072 | Acetylcholine M4 receptor antagonist | |||
| 0.034 | 0.017 | 0.034 | Cyclophilin A inhibitor | |||
| 0.034 | 0.018 | 0.034 | Prostaglandin agonist | 0.034 0.018 CID_992 | ||
| 0.125 | 0.109 | 0.125 | Phospholipase A2 inhibitor | 0.119 0.118 CID_992 | ||
| 0.054 | 0.038 | 0.054 | Thromboxane antagonist | |||
| 0.031 | 0.015 | 0.037 | Estrogen-related receptor gamma antagonist | 0.037 0.007 CID_992 | CID_992 | |
| 0.053 | 0.037 | 0.053 | Dipeptidyl peptidase inhibitor | |||
| 0.04 | 0.024 | 0.046 | Farnesoid X receptor agonist | 0.046 0.017 CID_992 | CID_992 | |
| 0.028 | 0.012 | 0.028 | Acid ceramidase inhibitor | |||
| 0.036 | 0.02 | 0.036 | Carnitine palmitoyltransferase inhibitor | |||
| 0.061 | 0.045 | 0.061 | Prostaglandin F2 alpha antagonist | |||
| 0.036 | 0.02 | 0.036 | Adenosine uptake inhibitor | |||
| 0.056 | 0.04 | 0.06 | Leukotriene C antagonist | 0.06 0.03 CID_992 | CID_992 | |
| 0.033 | 0.018 | 0.033 | AMPA 3 receptor antagonist | |||
| 0.025 | 0.01 | 0.027 | Isoleucine-tRNA ligase inhibitor | 0.027 0.008 CID_992 | CID_992 | |
| 0.021 | 0.006 | 0.021 | CC chemokine 9 receptor antagonist | 0.016 0.014 CID_992 | ||
| 0.029 | 0.014 | 0.029 | Prostaglandin H2 antagonist | 0.024 0.019 CID_992 | ||
| 0.026 | 0.011 | 0.03 | Prostaglandin F2 alpha agonist | 0.03 0.009 CID_992 | CID_992 | |
| 0.048 | 0.033 | 0.048 | Cytokine production stimulant | |||
| 0.038 | 0.023 | 0.038 | Progesterone antagonist | |||
| 0.027 | 0.012 | 0.027 | Kainate receptor 1 antagonist | |||
| 0.034 | 0.02 | 0.057 | Estradiol 17 beta-dehydrogenase 3 inhibitor | 0.057 0.009 CID_992 | CID_992 | |
| 0.089 | 0.074 | 0.105 | Interleukin 1 beta converting enzyme inhibitor | 0.105 0.051 CID_992 | CID_992 | |
| 0.034 | 0.02 | 0.034 | Dipeptidyl peptidase II inhibitor | |||
| 0.085 | 0.071 | 0.085 | MAO B inhibitor | |||
| 0.018 | 0.004 | 0.018 | Thromboxane agonist | 0.012 0.007 CID_992 | ||
| 0.018 | 0.004 | 0.018 | Carbonic anhydrase XI inhibitor | |||
| 0.09 | 0.076 | 0.09 | MAP kinase kinase kinase inhibitor | |||
| 0.05 | 0.036 | 0.05 | Thromboxane A2 antagonist | |||
| 0.039 | 0.025 | 0.039 | Diamine oxidase inhibitor | |||
| 0.021 | 0.008 | 0.021 | Carbonic anhydrase VIII inhibitor | 0.016 0.012 CID_992 | ||
| 0.021 | 0.008 | 0.021 | Carbonic anhydrase X inhibitor | 0.016 0.012 CID_992 | ||
| 0.032 | 0.019 | 0.032 | Prostaglandin EP3 antagonist | |||
| 0.069 | 0.056 | 0.069 | Peroxisome proliferator-activated receptor gamma antagonist | |||
| 0.025 | 0.012 | 0.025 | Protease (Human cytomegalovirus) inhibitor | |||
| 0.022 | 0.009 | 0.022 | Alpha 2c adrenoreceptor agonist | |||
| 0.059 | 0.047 | 0.059 | 5 Hydroxytryptamine 5A antagonist | |||
| 0.021 | 0.008 | 0.021 | Complement factor D inhibitor | |||
| 0.111 | 0.099 | 0.111 | Calcium channel blocker | |||
| 0.02 | 0.008 | 0.02 | Sodium/hydrogen exchanger inhibitor | |||
| 0.056 | 0.044 | 0.059 | Aromatase inhibitor | 0.059 0.042 CID_992 | CID_992 | |
| 0.041 | 0.029 | 0.041 | Sphingosine kinase 1 inhibitor | 0.038 0.036 CID_992 | ||
| 0.035 | 0.024 | 0.035 | Retinoid X alpha receptor agonist | |||
| 0.049 | 0.038 | 0.049 | Dihydroorotate dehydrogenase inhibitor | |||
| 0.032 | 0.021 | 0.032 | Cholesterol ester transfer protein antagonist | |||
| 0.019 | 0.008 | 0.024 | Telomerase stimulant | 0.024 0.005 CID_992 | CID_992 | |
| 0.028 | 0.017 | 0.028 | Myristoyl transferase inhibitor | |||
| 0.024 | 0.013 | 0.024 | Geranylgeranyltransferase inhibitor | |||
| 0.025 | 0.014 | 0.025 | Prostaglandin E2 agonist | 0.024 0.015 CID_992 | ||
| 0.097 | 0.086 | 0.097 | Anesthetic local | |||
| 0.033 | 0.022 | 0.033 | Vanilloid 4 antagonist | |||
| 0.029 | 0.018 | 0.029 | DNA polymerase III inhibitor | |||
| 0.033 | 0.023 | 0.033 | Sirtuin 2 inhibitor | |||
| 0.013 | 0.003 | 0.013 | DNA topoisomerase III inhibitor | 0.009 0.004 CID_992 | ||
| 0.089 | 0.079 | 0.089 | Nitric-oxide synthase inhibitor | |||
| 0.036 | 0.026 | 0.036 | Delayed rectifier potassium channel activator | |||
| 0.036 | 0.026 | 0.036 | Potassium channel KCNQ activator | |||
| 0.013 | 0.003 | 0.013 | DNA polymerase III subunit alpha inhibitor | |||
| 0.019 | 0.01 | 0.019 | Methylmalonyl-CoA mutase inhibitor | 0.019 0.01 CID_992 | ||
| 0.06 | 0.05 | 0.068 | Beta 2 adrenoreceptor agonist | 0.068 0.023 CID_992 | CID_992 | |
| 0.019 | 0.01 | 0.026 | Nicotinic acid receptor 1 antagonist | 0.026 0.005 CID_992 | CID_992 | |
| 0.019 | 0.01 | 0.019 | CXC chemokine 5 receptor antagonist | |||
| 0.014 | 0.004 | 0.014 | Progesterone receptor A antagonist | 0.009 0.007 CID_992 | ||
| 0.03 | 0.021 | 0.03 | Acetylcholine M4 receptor agonist | |||
| 0.046 | 0.037 | 0.046 | Carnitine palmitoyltransferase 1B inhibitor | |||
| 0.018 | 0.009 | 0.018 | Nicotinic alpha4 receptor agonist | |||
| 0.025 | 0.017 | 0.025 | Lysophosphatidic acid receptor 1 agonist | |||
| 0.015 | 0.007 | 0.015 | Integrin alphaLbeta2 antagonist | |||
| 0.063 | 0.055 | 0.063 | Potassium channel (ATP-sensitive) blocker | |||
| 0.028 | 0.02 | 0.028 | Thrombin receptor antagonist | |||
| 0.015 | 0.007 | 0.015 | Integrin beta2 antagonist | |||
| 0.034 | 0.026 | 0.034 | Growth hormone secretagogue receptor antagonist | |||
| 0.047 | 0.039 | 0.047 | Neurokinin antagonist | |||
| 0.099 | 0.092 | 0.099 | MAO inhibitor | |||
| 0.056 | 0.048 | 0.056 | Acetylcholine M5 receptor antagonist | |||
| 0.06 | 0.053 | 0.063 | Interferon inducer | 0.063 0.047 CID_992 | CID_992 | |
| 0.012 | 0.005 | 0.012 | Corticotropin releasing factor antagonist | |||
| 0.087 | 0.079 | 0.087 | Alpha 2c adrenoreceptor antagonist | |||
| 0.139 | 0.132 | 0.179 | I kappa B kinase epsilon inhibitor | 0.179 0.09 CID_992 | CID_992 | |
| 0.042 | 0.035 | 0.044 | AICAR transformylase inhibitor | 0.044 0.031 CID_992 | CID_992 | |
| 0.077 | 0.071 | 0.087 | Ornithine decarboxylase inhibitor | 0.087 0.059 CID_992 | CID_992 | |
| 0.021 | 0.014 | 0.021 | Retinoid X beta receptor antagonist | 0.019 0.018 CID_992 | ||
| 0.049 | 0.043 | 0.049 | Cannabinoid CB2 receptor agonist | |||
| 0.03 | 0.024 | 0.03 | Epoxide hydrolase 1 inhibitor | |||
| 0.017 | 0.011 | 0.017 | Prokineticin receptor 1 antagonist | |||
| 0.035 | 0.029 | 0.035 | Melanocortin 1 antagonist | |||
| 0.016 | 0.01 | 0.018 | Purinergic P2Y1 agonist | 0.018 0.008 CID_992 | CID_992 | |
| 0.058 | 0.053 | 0.058 | Phosphodiesterase 1C inhibitor | |||
| 0.013 | 0.008 | 0.016 | Glutamate (mGluR6) agonist | 0.016 0.005 CID_992 | CID_992 | |
| 0.053 | 0.049 | 0.053 | 5 Hydroxytryptamine 5 antagonist | |||
| 0.046 | 0.041 | 0.054 | Topoisomerase II beta inhibitor | 0.054 0.027 CID_992 | CID_992 | |
| 0.025 | 0.021 | 0.026 | Lysine carboxypeptidase inhibitor | 0.026 0.019 CID_992 | CID_992 | |
| 0.025 | 0.02 | 0.035 | Thyroid hormone agonist | 0.035 0.008 CID_992 | CID_992 | |
| 0.015 | 0.011 | 0.015 | Dipeptidyl peptidase VIII inhibitor | |||
| 0.067 | 0.064 | 0.067 | ErbB-2 antagonist | |||
| 0.023 | 0.02 | 0.023 | Glutamate (mGluR1) agonist | 0.023 0.021 CID_992 | ||
| 0.013 | 0.01 | 0.013 | Lysophosphatidic acid receptor 3 agonist | |||
| 0.071 | 0.068 | 0.075 | Interferon agonist | 0.075 0.061 CID_992 | CID_992 | |
| 0.06 | 0.056 | 0.073 | Beta adrenoreceptor antagonist | 0.073 0.034 CID_992 | CID_992 | |
| 0.099 | 0.096 | 0.301 | Interleukin 2 antagonist | 0.301 0.004 CID_992 | CID_992 | |
| 0.02 | 0.017 | 0.02 | Factor XIII inhibitor | |||
| 0.066 | 0.063 | 0.066 | Alpha 2a adrenoreceptor antagonist | |||
| 0.014 | 0.012 | 0.014 | NMDA receptor phencyclidine site antagonist | |||
| 0.039 | 0.037 | 0.039 | Neurokinin 3 antagonist | |||
| 0.033 | 0.031 | 0.033 | Glutamate (mGluR8) antagonist | |||
| 0.042 | 0.04 | 0.042 | Melanocortin antagonist | |||
| 0.095 | 0.093 | 0.095 | Calcium channel (voltage-sensitive) blocker | |||
| 0.044 | 0.041 | 0.044 | Carbonic anhydrase XIV inhibitor | |||
| 0.101 | 0.099 | 0.101 | Sphingosine 1-phosphate receptor 2 agonist | |||
| 0.058 | 0.056 | 0.058 | Neuronal nicotinic receptor antagonist | |||
| 0.017 | 0.016 | 0.017 | Potassium channel (Inward rectifier) 11 blocker | |||
| 0.053 | 0.051 | 0.053 | Sphingosine 1-phosphate receptor 3 antagonist | |||
| 0.05 | 0.049 | 0.05 | Dopamine D4 antagonist | |||
| 0.023 | 0.022 | 0.023 | Melanocortin 5 antagonist | |||
| 0.006 | 0.005 | 0.006 | Integrin alpha5beta6 antagonist | |||
| 0.036 | 0.035 | 0.036 | Protein kinase (CK1) epsilon inhibitor | |||
| 0.067 | 0.066 | 0.067 | Orexin receptor 1 antagonist | |||
| 0.032 | 0.031 | 0.032 | 5 Hydroxytryptamine 3B antagonist | |||
| 0.017 | 0.018 | 0.022 | Antibiotic Anthracycline-like | 0.022 0.008 CID_992 | CID_992 | |
| 0.036 | 0.037 | 0.039 | Leukotriene C4 antagonist | 0.039 0.027 CID_992 | CID_992 | |
| 0.044 | 0.045 | 0.103 | Aldose reductase inhibitor | 0.103 0.017 CID_992 | CID_992 | |
| 0.033 | 0.036 | 0.059 | Urate transporter 1 inhibitor | 0.059 0.014 CID_992 | CID_992 | |
| 0.031 | 0.034 | 0.04 | Inosine monophosphate dehydrogenase inhibitor | 0.04 0.021 CID_992 | CID_992 | |
| 0.009 | 0.017 | 0.011 | Egl nine homolog 3 inhibitor | 0.011 0.01 CID_992 | CID_992 | |
| 0.083 | 0.092 | 0.102 | Expectorant | 0.102 0.066 CID_992 | CID_992 | |
| 0.05 | 0.059 | 0.076 | Adenine nucleotide translocase inhibitor | 0.076 0.011 CID_992 | CID_992 | |
| 0.005 | 0.016 | 0.008 | Thyroid hormone beta agonist | 0.008 0.007 CID_992 | CID_992 | |
| 0.015 | 0.026 | 0.019 | Estrogen-related receptor gamma agonist | 0.019 0.013 CID_992 | CID_992 | |
| 0.088 | 0.104 | 0.166 | Alkylator | 0.166 0.039 CID_992 | CID_992 | |
| 0.028 | 0.046 | 0.065 | Estradiol 17 beta-dehydrogenase inhibitor | 0.065 0.017 CID_992 | CID_992 | |
| 0.037 | 0.057 | 0.054 | Beta 2 adrenoreceptor antagonist | 0.054 0.031 CID_992 | CID_992 | |
| 0.117 | 0.136 | 0.139 | CC chemokine 6 receptor antagonist | 0.139 0.043 CID_992 | CID_992 | |
| 0.078 | 0.099 | 0.095 | Xanthine oxidase inhibitor | 0.095 0.064 CID_992 | CID_992 | |
| 0.173 | 0.197 | 0.198 | Thioredoxin glutathione reductase inhibitor | 0.198 0.174 CID_992 | CID_992 | |
| 0.012 | 0.036 | 0.035 | Estradiol 17 beta-dehydrogenase 1 inhibitor | 0.035 0.01 CID_992 | CID_992 | |
| 0.128 | 0.156 | 0.715 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | 0.715 0.005 CID_992 | CID_992 | |
| 0.039 | 0.068 | 0.044 | Beta adrenoreceptor agonist | 0.044 0.036 CID_992 | CID_992 | |
| 0.038 | 0.07 | 0.066 | CXC chemokine 1 receptor antagonist | 0.066 0.016 CID_992 | CID_992 | |
| 0.06 | 0.094 | 0.078 | Adrenaline agonist | 0.078 0.06 CID_992 | CID_992 | |
| 0.075 | 0.114 | 0.345 | Estrogen receptor beta antagonist | 0.345 0.005 CID_992 | CID_992 | |
| 0.032 | 0.073 | 0.049 | Xanthine dehydrogenase inhibitor | 0.049 0.047 CID_992 | CID_992 | |
| 0.061 | 0.108 | 0.096 | Monophenol monooxygenase inhibitor | 0.096 0.079 CID_992 | CID_992 | |
| 0.121 | 0.174 | 0.695 | Dyrk kinase inhibitor | 0.695 0.005 CID_992 | CID_992 | |
| 0.062 | 0.118 | 0.088 | Mediator release inhibitor | 0.088 0.083 CID_992 | CID_992 | |
| 0.008 | 0.072 | 0.019 | Thyroid hormone alpha agonist | 0.019 0.008 CID_992 | CID_992 | |
| 0.04 | 0.111 | 0.269 | CDC25B inhibitor | 0.269 0.004 CID_992 | CID_992 | |
| 0.079 | 0.156 | 0.471 | Estrogen antagonist | 0.471 0.004 CID_992 | CID_992 | |
| 0.011 | 0.126 | 0.048 | Dopamine D5 antagonist | 0.048 0.026 CID_992 | CID_992 | |
| 0.065 | 0.227 | 0.184 | Mcl-1 antagonist | 0.184 0.065 CID_992 | CID_992 | |
| 0.07 | 0.25 | 0.288 | Amyloid beta precursor protein antagonist | 0.288 0.02 CID_992 | CID_992 | |
| 0.015 | 0.196 | 0.047 | Estrogen-related receptor beta antagonist | 0.047 0.007 CID_992 | CID_992 | |
| 0.158 | 0.341 | 0.39 | Apoptosis agonist | 0.39 0.118 CID_992 | CID_992 | |
| 0.005 | 0.188 | 0.03 | Thyroid hormone alpha antagonist | 0.03 0.005 CID_992 | CID_992 | |
| 0.007 | 0.214 | 0.16 | Estradiol 17 beta-dehydrogenase 2 inhibitor | 0.16 0.004 CID_992 | CID_992 | |
| 0.008 | 0.255 | 0.042 | Catechol O-methyltransferase inhibitor | 0.042 0.013 CID_992 | CID_992 | |
| 0.003 | 0.265 | 0.07 | Estrogen receptor alpha agonist | 0.07 0.013 CID_992 | CID_992 | |
| 0.022 | 0.337 | 0.155 | HIV-1 integrase inhibitor | 0.155 0.008 CID_992 | CID_992 | |
| 0.007 | 0.33 | 0.015 | Antibiotic Tetracycline-like | 0.015 0.013 CID_992 | CID_992 | |
| 0.098 | 0.435 | 0.442 | Caspase 3 stimulant | 0.442 0.032 CID_992 | CID_992 | |
| 0.036 | 0.387 | 0.176 | Interleukin-1 receptor-associated protein kinase 1 inhibitor | 0.176 0.078 CID_992 | CID_992 | |
| 0.003 | 0.371 | 0.055 | Estrogen receptor beta agonist | 0.055 0.018 CID_992 | CID_992 | |
| 0.008 | 0.391 | 0.221 | HIV-1 integrase (Strand Transfer) inhibitor | 0.221 0.008 CID_992 | CID_992 | |
| 0.013 | 0.414 | 0.042 | GHS receptor agonist | 0.042 0.03 CID_992 | CID_992 | |
| 0.008 | 0.425 | 0.224 | HIV-1 integrase (3'-Processing) inhibitor | 0.224 0.008 CID_992 | CID_992 | |
| 0.081 | 0.593 | 0.181 | Peptidyltransferase inhibitor | 0.181 0.127 CID_992 | CID_992 | |
| 0.004 | 0.547 | 0.111 | Estrogen agonist | 0.111 0.015 CID_992 | CID_992 | |
| 0.057 | 0.627 | 0.24 | Apoptosis antagonist | 0.24 0.137 CID_992 | CID_992 | |
| 0.018 | 0.626 | 0.193 | Interleukin antagonist | 0.193 0.088 CID_992 | CID_992 | |
| 0.067 | 0.687 | 0.206 | Interleukin 2 agonist | 0.206 0.178 CID_992 | CID_992 | |
| 0.007 | 0.649 | 0.125 | Leukotriene synthesis inhibitor | 0.125 0.015 CID_992 | CID_992 | |
| 0.015 | 0.672 | 0.252 | Antioxidant | 0.252 0.083 CID_992 | CID_992 | |
| 0.008 | 0.75 | 0.46 | Uric acid excretion stimulant | 0.46 0.004 CID_992 | CID_992 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |